Searchable abstracts of presentations at key conferences in endocrinology

ea0012p4 | Bone | SFE2006

Audit on the efficacy of intravenous Pamidronate in the treatment of osteoporosis

Arefin AN , Orme SM

IntroductionOsteoporosis is a common disease characterised by a decrease in bone mass attributed to an imbalance between bone formation and resorption. Oral bisphosphonates have proven efficacy in increasing bone mineral density (BMD) and fracture reduction. Prior to the introduction of i.v. Ibandronate, patients who were unable to tolerate oral bisphosphonate were treated with i.v. Pamidronate (APD).AimTo as...

ea0012p30 | Clinical case reports/Governance | SFE2006

A case of Gitelman’s syndrome, a variant of Bartter’s syndrome

Arefin AN , Nagi D

A 22-year old lady was referred with a history of fatigue, generalised aches and pains. Investigations revealed persistently low potassium on few occasions. There was no history of diarrhoea or vomiting. No laxative, diuretic or liquorice abuse. PMH: treated hypothyroidism and Idiopathic thrombocytopenic purpura. She weighed 46 kg and her BP was 115/63. Further investigations: sodium 140 mmol/l, potassium 2.6 mmol/l (3.5–5.0), bicarbonate 28 mmol/l (22–28), magnesium...

ea0010p10 | Clinical case reports/Governance | SFE2005

Krukenberg tumour with virilization: A case report

Arefin A , Anthoney A , Belchetz P

Introduction: Krukenberg tumour is an ovarian metastasis of G I tract cancer; Accounting for 1 to 2% of all ovarian tumours. It is usually bilateral and more common in premenopausal compared to menopausal women. Krukenberg tumours are rare but virilizing Krukenberg tumours are even rarer. We report a case of virilizing Krukenberg tumour.A 58-year-old Caucasian lady who was diagnosed with inoperable metastatic gastric adenocarcinoma, ascites and bilateral...

ea0010p41 | Endocrine tumours and neoplasia | SFE2005

An audit on hypercalcaemia. Tools of the trade

Arefin A , White C

Introduction: Primary hyperparathyroidism (PHP) is common; Prevalence and Incidence are now much higher than the past. There is also a change in practice related to medical management, surveillance, and defining criteria for diagnosis as well as the recommendation for surgery.Decision to send patients for surgery was considered primarily on their calcium level.Other criteria for surgery were largely ignored.E...

ea0050ep062 | Neoplasia, Cancer and Late Effects | SFEBES2017

Parathyroid adenoma, pituitary macroadenoma and raised gastrin levels in a patient with negative genetic testing for Multiple Endocrine Neoplasia Type 1: a mere coincidence?

Arefin Aamer Rashad , Hay Cathy

Background: Multiple Endocrine Neoplasia Type 1 (MEN1) is a rare autosomal dominant syndrome that predisposes individuals to multiple endocrine tumours, predominantly affecting the parathyroid, anterior pituitary and pancreatic islet cells. This unusual case shows features of three of the main MEN1 tumour types, yet genetic testing was negative for the MEN1 mutation.Case esentation: A 56-year-old lady first presen...

ea0050ep062 | Neoplasia, Cancer and Late Effects | SFEBES2017

Parathyroid adenoma, pituitary macroadenoma and raised gastrin levels in a patient with negative genetic testing for Multiple Endocrine Neoplasia Type 1: a mere coincidence?

Arefin Aamer Rashad , Hay Cathy

Background: Multiple Endocrine Neoplasia Type 1 (MEN1) is a rare autosomal dominant syndrome that predisposes individuals to multiple endocrine tumours, predominantly affecting the parathyroid, anterior pituitary and pancreatic islet cells. This unusual case shows features of three of the main MEN1 tumour types, yet genetic testing was negative for the MEN1 mutation.Case esentation: A 56-year-old lady first presen...

ea0013p49 | Clinical practice/governance and case reports | SFEBES2007

Severe cushing’s syndrome associated with metastatic prostate adenocarcinoma

Elmalti Akrem , Arefin AN , Thomas M , Jenkins R , Orme S

Introduction: Prostate carcinoma is a recognised yet rare cause of Cushing’s syndrome. This report describes two cases in which Cushing’s syndrome was associated with advanced prostate cancer.Case 1: A 70-year man presented with a very short history of swelling of his face and legs. He was known to have prostate adenocarcinoma with bony metastases. He was hypokalaemic and resistant to standard potassium replacement. He had a Cushingoid appearan...